Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
(Hunterbrook Media, the editorial affiliate of hedge fund Hunterbrook Capital, recently conducted an investigation into Hims & Hers Healths entry into the GLP-1 market, and one of its employees was offered compounded GLP-1 meds without their BMI being verified
The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
The formulary is a list of all the medications covered by an insurance plan, along with their corresponding pricing tiers
Lets break down what that means
In addition to no longer advertising or selling to U.S
US$ 27.64
US$ 24.00
US$ 27.51
